Please complete the CAPTCHA to continue
@allergan.com
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
John Donello is listed as Senior Biopharma Executive | Drug Hunter | Scientific Innovator | Entrepreneur | People Leader | Start-Up based in Park City, Utah, United States. AeroLeads shows a work email signal at allergan.com and a matched LinkedIn profile for John Donello.
John Donello previously worked as Vice President at Abbvie and Vice President, External Science & Innovation, and Research Pharmacology at Allergan. John Donello holds Doctor Of Philosophy - Phd, Biology from Uc San Diego.
This section adds company-level context without repeating John Donello's masked contact details.
AeroLeads found 1 current-domain work email signal for John Donello. Compare company email patterns before reaching out.
Pharmaceutical industry executive and innovator with over 20 years of pharmaceutical experience initiating and leading multi-disciplinary R&D in ophthalmology, medical aesthetics, dermatology, and neuroscience. Managed complex, global collaborative drug research and development biotechnology partnerships, acquisition integrations, and global development program teams. Leadership emphasis on building a collaborative culture and developing critical talent that focuses on translating pioneering science and early stage technologies into late stage clinical product success. Extensive scientific and management experience with increasing strategic, and portfolio leadership responsibilities from non-clinical drug discovery through Phase II POC. Inventor of greater than 100 granted US patents, initiated discovery and global development of multiple drug candidates currently undergoing clinical investigation, and successfully out-licensed multiple innovative drug product platforms.
Listed skills include Pharmaceutical Industry, Biotechnology, Science, Laboratory, and 8 others.
A career timeline built from the work history available for this profile.
North Chicago, Illinois, US
Following the Abbvie acquisition of Allergan, responsbilities included the transition and integration of Allergan research and development projects with Abbvie and out-licensing of de-prioritized AGN assets.
Dublin, Coolock, IE
Executive leader within the innovation community, including KOLs, biotech and venture capital firms. Led groups that oversaw the proactive search, assessment, due diligence, and recommendations to EVP AGN R&D for acquisition/partnership opportunities in ophthalmology, CNS, medical aesthetics, and GI. Partner with business development, and lead internal.
Dublin, Coolock, IE
Oversaw strategic and organizational structural re-alignment, change management, and scientific oversight of revamped small molecule ophthalmology and neuroscience research and early clinical development. Strategic focus on novel target/NCE discovery balanced with drug re-purposing for key, high priority indications.
Dublin, Coolock, IE
Directed new target discovery, validation, and validated target small molecule pharmacology in ophthalmology including glaucoma, retina, dry eye, post-surgical inflammation, and presbyopia. Oversight of new dedicated repurposing effort and human genetic collaboration focused in retina disease. Led multiple multi-disciplinary development teams, with.
Dublin, Coolock, IE
Governed the formation of new target-based lead optimization teams, and oversaw integrated Discovery team activities in the areas of ophthalmology, pain, and neurodegenerative diseases. Led NCE development of first in class pharmacology into Phase I-II early development for pain and cognition, including oversight of clinical and regulatory strategy for.
Dublin, Coolock, IE
Led transatlantic collaboration to identify new drug targets for pain, ophthalmology, Alzheimer’s and shepherded molecules pre-clinical development. Key responsibilities included leading a multi-disciplinary team of ~ 25 individuals (including chemists, biologists, toxicologists, pharmacokineticists), identifying key resources for team, management of team.
Dublin, Coolock, IE
Initiated transatlantic genomic and genetic collaboration to identify and initiate discovery activities on new drug targets. Developed strategy and formation of new Discovery team (Platform Discovery Team) dedicated to the discovery of novel drug targets. Responsible for pharmacology strategy and representation of clinical stage candidates, pharmacology.
Dublin, Coolock, IE
Developed genomic and pharmacology projects to identify and assess novel pain and retinal neuroprotection drug targets, and performed functional genomics and pharmacology studies to nominate NCEs into early development.
Dublin, Coolock, IE
Initiated new technology efforts including high throughput screening and functional genomics. Investigated the neuroprotective mechanism of the alpha2 agonist brimonidine in glaucoma.
Dublin, Coolock, IE
Cloned the human EP2, EP3, EP4, FP, and TP receptors and expressed the receptors to support the prostaglandin/ Lumigan medicinal chemistry effort.
Quick answers generated from the profile data available on this page.
John Donello is listed as Senior Biopharma Executive | Drug Hunter | Scientific Innovator | Entrepreneur | People Leader | Start-Up.
AeroLeads has found 1 work email signal at @allergan.com for John Donello.
John Donello is based in Park City, Utah, United States.
John Donello has worked for Abbvie and Allergan.
You can use AeroLeads to view verified contact signals for John Donello, including work email, phone, and LinkedIn data when available.
John Donello holds Doctor Of Philosophy - Phd, Biology from Uc San Diego.
John Donello is listed with skills including Pharmaceutical Industry, Biotechnology, Science, Laboratory, Drug Discovery, Neuroscience, Clinical Development, and Oncology.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts